Evidence map›Paper›PMID 39941771›Full record

ArticleCancers2025

Immunotherapy-Related Adverse Events and Clinical Outcomes in Adult Solid-Tumor Patients Admitted to an Onco-Hospitalist Medicine Service.

Cesar Simbaqueba Clavijo, Orhue Odaro, Ayush Gandhi, Kwame Koom-Dadzie, Arine Musaelyan, Kodwo Dickson, Rosalie Chua, Viraj Bhise, Magdelene Amoateng, Sophy Tomy and 8 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancers, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Cesar Simbaqueba ClavijoDepartment of Hospital Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Orhue OdaroDepartment of Hospital Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.ORCID 0000-0002-8115-7899
Ayush GandhiDepartment of Hospital Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.ORCID 0009-0008-8508-152X
Kwame Koom-DadzieDepartment of Hospital Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.ORCID 0000-0002-6365-9203
Arine MusaelyanDepartment of Hospital Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Kodwo DicksonDepartment of Hospital Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Rosalie ChuaDepartment of Hospital Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.ORCID 0009-0002-0723-5729
Viraj BhiseDepartment of Hospital Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Magdelene AmoatengDepartment of Hospital Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Sophy TomyDepartment of Hospital Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Daniel Leal AlviarezDepartment of Hospital Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Ei Moe PhyuDepartment of Hospital Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Ivana BogdanichPharmacy Clinical Programs, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Clark AndersenDepartment of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.ORCID 0000-0003-1846-9117
Ajay SheshadriDepartment of Pulmonary Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Nicolas L PalaskasDepartment of Cardiology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.ORCID 0000-0001-7565-1797
Josiah HalmDepartment of Hospital Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Joanna ManzanoDepartment of Hospital Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.ORCID 0000-0001-6505-6425

Funding

The University of Texas MD Anderson Cancer Center and a Cancer Center Support Grant from the National Institutes of Health/National Cancer Institute P30CA016672
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

hospitalisthospital medicineimmune checkpoint inhibitorimmune-related adverse eventimmunotherapyimmunotherapy–organ toxicity

Identifiers

PMID39941771
PMCPMC11816018

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.